A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.

Adriana Maria Paixão de Sousa da Silva Lara de Castro Barbosa Leticia Maria Acioli Marques Letícia Yasuda Carreira Fernanda Maria Casimiro da Fonseca Ana Paula Cordeiro Lima Janaína Joice Martins Sodré Luara Teofilo Pignati Orlei Ribeiro de Araújo Dafne Cardoso Bourguignon da Silva Fabianne Altruda de Moraes Costa Carlesse

Published in: Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo (2023)

C. difficile symptomatic infection in children with cancer was associated with previous hospitalization and the use of common antibiotics in cancer patients, such as vancomycin, meropenem, and cefepime, in the last 3 months. Chemotherapy drugs, such as carboplatin, melphalan, busulfan, and asparaginase, were also risk factors.

Keyphrases

papillary thyroid
risk factors
clostridium difficile
squamous cell
young adults
childhood cancer
high dose
methicillin resistant staphylococcus aureus
clinical trial
randomized controlled trial
squamous cell carcinoma
radiation therapy
acute care
multidrug resistant
acute myeloid leukemia
rectal cancer